Cargando…

Combined Central and Peripheral Demyelination With IgM Anti–Neurofascin 155 Antibodies: Case Report

Detalles Bibliográficos
Autores principales:	Pegat, Antoine, Delmont, Emilien, Svahn, Juliette, Bernard, Emilien, Lessard, Lola, Marignier, Romain, Bouhour, Francoise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Clinical/Scientific Note
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8936685/ https://www.ncbi.nlm.nih.gov/pubmed/35314490 http://dx.doi.org/10.1212/NXI.0000000000001160

Ejemplares similares

Neurofascin-155 as a putative antigen in combined central and peripheral demyelination
por: Cortese, Andrea, et al.
Publicado: (2016)

Autoantibodies to a Nodal Isoform of Neurofascin in Pediatric Chronic Inflammatory Demyelinating Polyneuropathy
por: Chauvet, Eline, et al.
Publicado: (2023)

Trigeminal Nerve Involvement in Bulbar-Onset Anti-IgLON5 Disease
por: Cluse, Florent, et al.
Publicado: (2023)

Optic Nerve Demyelination in IgG4 Anti–Neurofascin 155 Antibody–Positive Combined Central and Peripheral Demyelination Syndrome
por: Verghese, Alice, et al.
Publicado: (2021)

Clinical and Molecular Landscape of ALS Patients with SOD1 Mutations: Novel Pathogenic Variants and Novel Phenotypes. A Single ALS Center Study
por: Bernard, Emilien, et al.
Publicado: (2020)

Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti‐Neurofascin‐155 Antibodies
por: Bailly, Laurent, et al.
Publicado: (2018)

Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination
por: Efthymiou, Stephanie, et al.
Publicado: (2019)

Anti-Neurofascin 155 Antibody-Positive Chronic Inflammatory Demyelinating Polyneuropathy/Combined Central and Peripheral Demyelination: Strategies for Diagnosis and Treatment Based on the Disease Mechanism
por: Kira, Jun-ichi
Publicado: (2021)

Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy
por: Ogata, Hidenori, et al.
Publicado: (2015)

Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating Polyneuropathy
por: Belmokhtar, Chafké, et al.
Publicado: (2019)

Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
por: Rajabally, Yusuf A, et al.
Publicado: (2020)

IgG4 Valency Modulates the Pathogenicity of Anti–Neurofascin-155 IgG4 in Autoimmune Nodopathy
por: Jentzer, Alexandre, et al.
Publicado: (2022)

Intrathecal cytokine profile in neuropathy with anti‐neurofascin 155 antibody
por: Ogata, Hidenori, et al.
Publicado: (2019)

Neurofascin-155 Immunoglobulin Subtypes: Clinicopathologic Associations and Neurologic Outcomes
por: Shelly, Shahar, et al.
Publicado: (2021)

Structural insights into the contactin 1 – neurofascin 155 adhesion complex
por: Chataigner, Lucas M. P., et al.
Publicado: (2022)

Case report: Autoimmune nodopathy with concurrent serum and CSF IgG4 anti-neurofascin 155 antibodies
por: Wang, Wanyu, et al.
Publicado: (2022)

Peripheral nervous system involvement accompanies central nervous system involvement in anti-glial fibrillary acidic protein (GFAP) antibody-related disease
por: Theuriet, Julian, et al.
Publicado: (2023)

Optic, trigeminal, and facial neuropathy related to anti‐neurofascin 155 antibody
por: Ogata, Hidenori, et al.
Publicado: (2020)

Exophthalmos and Supraorbital Bulging in Anti-neurofascin-155 Antibody-positive Neuropathy
por: Machida, Akira
Publicado: (2023)

Anti-pan-neurofascin IgM in COVID-19-related Guillain-Barré syndrome: Evidence for a nodo-paranodopathy
por: Tard, Céline, et al.
Publicado: (2020)

Association of neurofascin IgG4 and atypical chronic inflammatory demyelinating polyneuropathy: A systematic review and meta‐analysis
por: Hu, Wenyu, et al.
Publicado: (2018)

Neurofascin (NF)155- and NF186-Specific T Cell Response in a Patient Developing a Central Pontocerebellar Demyelination after 10 Years of CIDP
por: Klehmet, Juliane, et al.
Publicado: (2017)

Anti-Neurofascin–Associated Nephrotic-Range Proteinuria in Chronic Inflammatory Demyelinating Polyneuropathy
por: Bukhari, Syed, et al.
Publicado: (2020)

Anti-NF155 chronic inflammatory demyelinating polyradiculoneuropathy strongly associates to HLA-DRB15
por: Martinez-Martinez, Laura, et al.
Publicado: (2017)

Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy
por: Doppler, Kathrin, et al.
Publicado: (2015)

Deletion of the Thrombin Proteolytic Site in Neurofascin 155 Causes Disruption of Nodal and Paranodal Organization
por: Dutta, Dipankar J., et al.
Publicado: (2021)

Clinical and diagnostic features of anti‐neurofascin‐155 antibody‐positive neuropathy in Han Chinese
por: Wang, Wenqing, et al.
Publicado: (2022)

Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
por: Bai, Yunfei, et al.
Publicado: (2023)

Selective inhibition of anti‐MAG IgM autoantibody binding to myelin by an antigen‐specific glycopolymer
por: Aliu, Butrint, et al.
Publicado: (2020)

Autosomal recessive pathogenic MSTO1 variants in hereditary optic atrophy
por: Gerber, Sylvie, et al.
Publicado: (2023)

Correction: Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy
por: Doppler, Kathrin, et al.
Publicado: (2015)

Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease
por: Warrington, A. E., et al.
Publicado: (2008)

Atypical chronic inflammatory demyelinating polyradiculoneuropathy with ophthalmoplegia and anti-sulfatide IgM positivity
por: Chen, Li, et al.
Publicado: (2023)

Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes
por: Diederich, Jan-Markus, et al.
Publicado: (2018)

Impact of Neurofascin on Chronic Inflammatory Demyelinating Polyneuropathy via Changing the Node of Ranvier Function: A Review
por: Gao, Ying, et al.
Publicado: (2021)

MOG antibodies in combined central and peripheral demyelination syndromes
por: Vazquez Do Campo, Rocio, et al.
Publicado: (2018)

Repeated treatments with rituximab in a patient with amyloid-like IgM deposition neuropathy
por: Kadoya, Masato, et al.
Publicado: (2016)

Childhood choreoathetosis secondary to hyper-IgM syndrome (CD40 ligand deficiency)
por: Coulter, Ian C., et al.
Publicado: (2020)

Focal loss of the paranodal domain protein Neurofascin155 in the internal capsule impairs cortically induced muscle activity in vivo
por: Kunisawa, Kazuo, et al.
Publicado: (2020)

Autoimmune Peripheral Neuropathies and Contribution of Antiganglioside/Sulphatide Autoantibody Testing
por: Roggenbuck, Dirk, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_p5c5446pdcksj2lj2ucfp2cqn8